PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsIboctadekin
Iboctadekin
Iboctadekin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
89 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SyndromeD013577——2——136
Diabetes mellitusD003920EFO_0000400E08-E13—1—124
Acute kidney injuryD058186—N17———123
Mucocutaneous lymph node syndromeD009080EFO_0004246M30.3——11—2
Liver cirrhosisD008103EFO_0001422K74.0———112
FibrosisD005355—————112
Periodontal diseasesD010510—K05.6———112
Acute coronary syndromeD054058EFO_0005672————112
Myocardial ischemiaD017202EFO_1001375I20-I25———112
Hepatitis cD006526—B19.2———1—1
Show 9 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.9321——5
Lymphoproliferative disordersD008232Orphanet_2442D47.9—13——4
X-linked genetic diseasesD040181———12——3
InfectionsD007239EFO_0000544——11—23
Iga deficiencyD017098EFO_1001929———2——2
Sars-cov-2D000086402———11——1
Ischemic strokeD000083242————1——1
StrokeD020521EFO_0000712I63.9——1——1
IschemiaD007511EFO_0000556———1——1
Cerebral infarctionD002544—I63——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InflammationD007249MP_0001845——1——67
Non-hodgkin lymphomaD008228—C85.951———6
NeoplasmsD009369—C8051———5
Covid-19D000086382—U07.1—2——13
Juvenile arthritisD001171EFO_1002007M0811——13
SepsisD018805EFO_0001420A41.9—1——12
ToxemiaD014115———1——12
Ovarian neoplasmsD010051EFO_0003893C5621———2
Ovarian epithelial carcinomaD000077216——21———2
MelanomaD008545——12———2
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C955————5
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.03————3
Colorectal neoplasmsD015179——3————3
Myeloid leukemia acuteD015470—C92.03————3
Myeloid leukemiaD007951—C923————3
RecurrenceD012008——3————3
Breast neoplasmsD001943EFO_0003869C501———12
B-cell chronic lymphocytic leukemiaD015451—C91.12————2
Myelodysplastic syndromesD009190—D462————2
Multiple myelomaD009101—C90.02————2
Show 15 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PeriodontitisD010518EFO_0000649K05.3————55
ObesityD009765EFO_0001073E66.9————33
Renal insufficiencyD051437—N19————33
Insulin resistanceD007333EFO_0002614E88.819————22
UrticariaD014581EFO_0005531L50————22
Aggressive periodontitisD010520EFO_0006342K05.2————22
Chronic periodontitisD055113EFO_0006343K05.3————22
Pediatric obesityD063766——————22
FeverD005334—R50.9————22
Stem cell transplantationD033581——————11
Show 65 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIboctadekin
INNiboctadekin
Description
Iboctadekin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Classification
Protein
Drug classinterleukins
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
>4HJJ:H|Anti-IL12 Anti-IL18 DFab Heavy Chain EVTLRESGPALVKPTQTLTLTCTFSGFSLSKSVMGVSWIRQPPGKALEWLAHIYWDDDKYYNPSLSARLTISKDTSKNQV VLTMTNMDPVDTATYYCARRGIRSAMDYWGQGTTVTVSSASTKGPEVQLVQSGTEVKKPGESLKISCKGSGYTVTSYWIG WVRQMPGKGLEWMGFIYPGDSETRYSPTFQGQVTISADKSFNTAFLQWSSLKASDTAMYYCARVGSGWYPYTFDIWGQGT MVTVSSASTKGPSVFPLAPSSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPS SSLGTQTYICNVNHKPSNTKVDKKVEPK >4HJJ:L|Anti-IL12 Anti-IL18 DFab Light Chain DIVMTQSPDSLAVSLGERATINCKASQSVSNDVAWYQQKPGQPPKLLIYYASNRYTGVPDRFSGSGSGTDFTLTISSLEA EDVAVYYCQQDYNSPWTFGGGTKVEIKRTVAAPEIVMTQSPATLSVSPGERATLSCRASESISSNLAWYQQKPGQAPRLF IYTASTRATDIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPSITFGQGTRLEIKRTVAAPSVFIFPPSDEQLK SGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVT KSFNRGE
Identifiers
PDB2VXT, 3F62, 3WO2, 3WO3, 3WO4, 4EEE, 4EKX, 4HJJ, 4R6U, 4XFS, 4XFT, 4XFU, 7AL7, 8J6K
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2108034
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDX08H9UZ7TO (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,396 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
5 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use